galactose has been researched along with aica ribonucleotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, Y; Sekimizu, K; Sugita, T; Sumiya, E | 1 |
| Ai, Q; Che, Q; Ge, P; Gong, X; Lin, L; Wan, J; Wen, A; Zhang, L; Zhou, D | 1 |
2 other study(ies) available for galactose and aica ribonucleotide
| Article | Year |
|---|---|
An invertebrate hyperglycemic model for the identification of anti-diabetic drugs.
Topics: Aminoimidazole Carboxamide; Animals; Bombyx; Carbohydrates; Diet; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding Behavior; Galactose; Glucose; Glycation End Products, Advanced; Hemolymph; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Ribonucleotides | 2011 |
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactose; Hepatitis, Animal; Humans; Hypoglycemic Agents; Lipopolysaccharides; Liver; Male; Mice; Molecular Targeted Therapy; Nitric Oxide; Ribonucleotides; Transaminases; Tumor Necrosis Factor-alpha | 2015 |